News

It is nowadays quite common that an employee who is used to working remotely in Finland to want to work remotely abroad for a certain period. For example, remote work abroad might be combined with a vacation or, alternatively, the employee escapes the Finnish winter to work remotely abroad. In addition to the employee’s own....

On February 9, 2023, Olshan Partner and Chair of the firm’s Shareholder Activism Practice Group Andrew Freedman will participate on a panel discussion entitled “Universal Proxy” at the second annual Palm Beach CorpGov Forum in Palm Beach, FL. With over 200 attendees, the event includes corporate directors and C-suite executives, institutional investors, pension funds, attorneys,....

The answer to the question “what makes a professional network strong” is multifaceted. However, one thing is clear: a network is only as strong as the relationships among its members. And this is cultivated at LAWorld in the form of regular get-togethers. The event proved once again that LAWorld is a unique and vibrant international....

SynAct Pharma AB, a Swedish listed biotechnology company (Nasdaq Stockholm: SYNACT), acquires 100% of TXP Pharma AG, a privately owned Swiss biotech company, researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. BGPartner assisted SynAct Pharma AB in the negotiations and advised on all Swiss legal matters regarding this international M&A....

Todd Serbin discusses key considerations for businesses around their international IP protection strategies, especially with respect to patents. The following video provides insights. https://www.youtube.com/watch?v=XvK2R3nrEls https://www.nexsenpruet.com/multimedia-international-ip-protection-strategies  Author: Todd Serbin tserbin@nexsenpruet.com +1 803.540.2185 Nexsen Pruet